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Abstract
G protein coupled receptors (GPCRs) allow for the transmission of signals across biological
membranes. For a number of GPCRs, this signaling was shown to be coupled to prior
dimerization of the receptor. The chemokine receptor type 4 (CXCR4) was reported before
to form dimers and their functionality was shown to depend on membrane cholesterol.
Here, we address the dimerization pattern of CXCR4 in pure phospholipid bilayers and in
cholesterol-rich membranes. Using ensembles of molecular dynamics simulations, we
show that CXCR4 dimerizes promiscuously in phospholipid membranes. Addition of cho-
lesterol dramatically affects the dimerization pattern: cholesterol binding largely abolishes
the preferred dimer motif observed for pure phospholipid bilayers formed mainly by trans-
membrane helices 1 and 7 (TM1/TM5-7) at the dimer interface. In turn, the symmetric
TM3,4/TM3,4 interface is enabled first by intercalating cholesterol molecules. These data
provide a molecular basis for the modulation of GPCR activity by its lipid environment.
Author Summary
The G protein coupled C-X-C chemokine receptor type 4 (CXCR4) is a transmembrane
receptor that plays an essential role in the human immune system. However, overexpres-
sion of CXCR4 has been shown to lead to metastasis of breast and lung cancer cells.
Furthermore, the HI-Virus infects T-cells through binding to CXCR4 resulting in immu-
nodeficiencyand AIDS. The function of CXCR4 as well as its interaction with HIV
depends on the presence of cholesterol in the cell membrane. Additionally, dimerization
of CXCR4 is considered to be functionally relevant. Here, using more than a thousand of
molecular dynamics simulations, we aim to connect the cholesterol-modulated function of
CXCR4 with a potentially cholesterol-conditioned dimerization. Our results show that the
dimerization pattern of CXCR4 is drastically altered by cholesterol. Further, we suggest
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that a functionally competent CXCR4 dimer is exclusively formed in the presence of cho-
lesterol, while the preferred CXCR4 dimer interface in the absence of cholesterol is shifted
to probably inactive forms.
Introduction
Signaling across cell barriers by G protein coupled receptors (GPCRs) is increasingly associated
with GPCR dimerization or more general oligomerization [1]. While G protein coupling was
shown for many GPCRs to not necessarily depend on dimerization, a direct coupling of func-
tion with homo- or hetero-dimerizationwas reported for a number of GPCRs from both class
A and class C [2–4].
The chemokine receptor type 4 (CXCR4) is supposed to form dimers for proper biological
activity [5]. This class A GPCR is responsible for directedmigration of cells (chemotaxis) in
nerve and immune cells of the human body [6, 7]. The overexpression of CXCR4 has been
shown to lead to metastasis [8] and increased levels of CXCR4 expression were in particular
found in breast and lung cancer cells [9]. Moreover, CXCR4 is known to be a major receptor
for the human immunodeficiencyvirus-1 (HIV-1) upon infecting human T-cells leading to
immunodeficiencyand AIDS [10]. CXCR4 dimers have been suggested to be either preformed,
induced, or stabilized by the interaction with its agonist CXCL12 [5, 11–13].
Function of CXCR4 requires the presence of cholesterol [14]. Cholesterol may influence
CXCR4 function by either inducing conformational changes upon binding or by cholesterol-
altered CXCR4 dimerization. So far, no direct proofs for either of those mechanisms exist. For
cancer cells, the chemotaxis response following CXCL12 binding to CXCR4 was abolished,
inhibiting CXCR4-mediated cell migration, if the receptor homodimerizationwas modulated
by removing cholesterol or blocked by a TM4 peptide (an analog of the transmembrane (TM)
helix 4 of CXCR4) [14, 15]. Another study revealed that the CXCL12-induced increase of the
bioluminescence resonance energy transfer (BRET)-signal intensity, was greatly reduced in
presence of TM4 peptides in living cells, whereas TM6 and TM7 peptides showed significantly
weaker influence [16]. In addition, CXCR4-mediated inhibition of cAMP production was
almost abolished due to the binding of TM4 peptides. These observations hint to a mechanism
where dimeric interfaces involving TM4 enable ligand-induced conformational changes which
are required for CXCR4 signaling.
Moreover, the dimerization of wildtype CXCR4 with a truncated form was shown to cause
theWHIM (Warts, Hypogammaglobulinemia, Infections and Myelokathexis) syndrome [17].
Structural information on GPCR dimerization or oligomerization interfaces mainly comes
from available crystal structures of class A GPCRs [18, 19] displaying preferred interfaces
under crystal conditions. Different dimer interfaces were found for various receptors: the trans-
membrane helix 1 (TM1) and helix 8 (H8) form the symmetric dimer interface of opsin [20]
and of the human β2-adrenergic GPCR [21]. TM1 and TM2 as well as H8 were found at the
symmetric interface of the human κ opioid receptor [22], and TM1,7 and H8 for rhodopsin
[23]. For the latter, atomic force microscopy data further hinted to TM4,5 as the physiological
interface [24]. For the C-C chemokine receptor type 5 (CCR5) a crystal packing with an asym-
metric interface including TM1,7 and H8 on one monomer and TM4,5 for the second was
obtained [25]. Some receptors even displayed different dimer configurations in different crys-
tals. E.g., for the β1-adrenergic GPCR both symmetric TM1,2,H8 as well as TM4,5 interfaces
were observed [26]. Also the high-resolution crystal structures of CXCR4 in complex with
either a small antagonist (IT1t), a cyclic antagoinst (CVX15), or a viral chemokine antagonist
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(vMIP-II) showed symmetric TM5,6 interfaces as the dominant dimerization interfaces [17,
27]. However, CXCR4 dimers were likewise formed by TM1/TM5-7 interactions, or displayed
TM1/TM1 as a dimerization interface (Fig 1).
Another important source of information about GPCR dimerization are in silicomolecular
dynamics (MD) simulations. Coarse-grained (CG) simulations allow to study GPCR self-
assembly on the microsecond timescale. The two commonly used techniques to obtain a statis-
tical view on the oligomerization process include simulations of multiple receptors [28, 29] and
multiple independent parallel dimerization or oligomerization simulations [29–31]. These in
silicomethods have shown that individual GPCRs may interact by different interfaces and sug-
gested for the β2-adrenergic receptor a possible modulation of the dimer interface by choles-
terol [31]. The strength of GPCR dimer interfaces may be approximated by analyzing the
potential of mean force [32, 33]. This methodologyhas shown that both the β1- and β2-adren-
ergic receptors prefer the symmetric TM1,H8 dimerization interface over the also symmetric
TM3,4 interface [32]. Rhodopsin also mostly favors the TM1,H8 interface, followed closely by
symmetric TM5 and TM4,5 interfaces [33].
A coupling betweenGPCR function and dimer interface configurationwas first shown by
cross linking experiments. These revealed that the homodimer interface of the dopamine
receptor (class A GPCR) differs considerably between active (TM4/TM4) and inactive
(TM4,5/TM4,5) states of the receptor [34]. Similarly, the metabotropic glutamate receptor
(mGluR, class C GPCR) adopts different dimer configurations depending on whether the
receptor is in its active (TM6/TM6) or inactive (TM4,5/TM4,5) state [35]. Differently, the sero-
tonine receptor (5HT2c, class A GPCR) was found to form both TM1/TM1 and TM4,5/TM4,5
dimers, however, only the latter dimer was activation sensitive [36]. While evidence for a cou-
pling of GPCR function and dimerization is increasing, it is not known whether activation
selects between different pre-existing GPCR dimer configurations or whether activation drives
a reorientation of the receptors in a dimer into an activation-compatible state.
A couple of recent crystal structures revealed intercalating cholesterol molecules within
assembled GPCR oligomers. In case of the A2A adenosine receptor, three cholesterol molecules
from the upper membrane leaflet were reported to intercalate at the TM1-TM3/TM5,6 dimer
Fig 1. Crystal structures and dimers of CXCR4. (a) Structure of CXCR4 in cartoon representation. The coloring of the TM is as follows: TM1 is
shown in red (Ala34-Gly64), TM2 in marine blue (Met72-Ala100), TM3 in yellow (Asn106-Val139), TM4 in grey (Gln145-Phe174), TM5 in magenta
(Asp193-Ser227), TM6 in dark blue (Leu238-Leu267), and TM7 in green (Cys274-Leu301). (b) Dimerization interfaces as observed in crystal
structures (pdb entries 3OE9 and 3OE8 [17]).
doi:10.1371/journal.pcbi.1005169.g001
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interface. The cholesterol molecules were bound between TM2 and TM3 and closely packed
around TM6 of the protomers [37]. The symmetric TM5,6/TM5,6 dimer interface of the
P2Y12 receptor was stabilized by two cholesterol molecules from the lower leaflet which inter-
calate betweenTM3 and TM5 of the protomers [38]. Interestingly, the antagonist-bound, (and
thus considered inactive) μ-opioid receptors shows a symmetric dimer interface involving
TM5, TM6 and cholesterol bound to TM6 [39]. Also for the agonist-bound receptor, in orches-
tra with a G protein mimetic fragment coupled to the intracellular part, a cholesterol molecule
bound to TM6. However, the dimerization via symmetric TM5,6 interactions was disabled due
to the outwards movement of the lower part of TM6 [40]. On the other hand, the symmetric
TM1,2,H8/TM1,2,H8 dimer (also formed in the inactive state) could still be observed.These
observations from different GPCR dimer structures further support the hypothesis that GPCR
dimer interfaces may differ between active and inactive configurations. Furthermore, choles-
terol binding appears to be receptor specific and thus hard to classify in a general way.
Here, we report a combined coarse-grained and atomistic simulation study of the dimeriza-
tion of the chemokine receptor type 4, showing a promiscuous, however, specific binding pat-
tern of CXCR4 in a phospholipid bilayer. Our study further pinpoints how cholesterol binding
to a specific binding site on TM1,7 largely suppresses the formation of a dimer interface involv-
ing TM6, which was reported to be essential in receptor activation [41]. In contrast, choles-
terol-rich domains are shown to favor a symmetrical TM3,4 dimer interface of CXCR4. These
findings connect the experimental observations that CXCR4 signaling is cholesterol-dependent
and that the TM4 helix is a key player in building up signaling-competent homodimer inter-
faces in a molecularmanner.
Results
The dimerization of CXCR4 in absence and presence of cholesterol was studied using ensem-
bles of MD simulations at a coarse-grained level. In total, we performed 1,500 coarse-grained
simulations of two CXCR4 monomers embedded in a phospholipid bilayer built of 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) molecules at 0%, 10%, and 30% choles-
terol content [30]. The receptors were initially separated by at least 3.5 nm, the simulation
lengths were 3 μs (0% cholesterol) and 6 μs (10% and 30% cholesterol) for every simulation,
accumulating to a total simulation time of 7.5 ms.
Promiscuous dimerization of CXCR4
Dimerization of CXCR4 in pure POPC was observed in 50% of all simulations within 3 μs
(For a sample dimerization process see S1 Video). Addition of cholesterol led to a markedly
decreased dimerization: Association was obtained in 29% of all simulations at 10% cholesterol
concentration, and only 10% of the systems dimerized at 30% cholesterol content within 3 μs
(145 and 53 simulations resulting in dimer formation, respectively, (see S1 Fig)). After 6 μs of
simulation time, 55% and 21% of the simulation systems at 10% and 30% cholesterol content,
respectively, showed dimerization. It is interesting to note that the decrease in dimerization
can not be attributed to the decrease in protein mobility only: cholesterol reduced the diffusion
coefficient of a monomeric receptor only by 25% and 50% (for 10% and 30% cholesterol,
respectively), compared to a corresponding decrease in dimerization by 42% and 79% (see
Materials and Methods). However, assuming a simple ‘hit-and-dimerize’ model, a reduced dif-
fusion coefficientwould lead to a proportionally decreased receptor dimerization. This finding
suggests that cholesterol affects dimerization either by changing the membrane properties or
by direct interaction with the receptors. For all dimerization simulations, the receptor did not
substantially affect the membrane thickness in its surrounding, i.e. the lipid bilayer frustration
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[42] is expected to be of minor importance for the dimerization in the POPC systems (compare
S1 Table). A few dissociation events of CXCR4 dimers could be observed, allowing to estimate
a lower bound for the binding free energy between -20 kJ/mol (30% cholesterol) and -24 kJ/
mol (pure POPC, seeMaterials and Methods).
Overall, an orientation analysis of the monomers in the sampled dimer structures revealed
seven different dimer configurations (Fig 2). The most populated dimers in pure POPC were a
compact asymmetric TM1/TM5-7 dimer (configurationB, population 26%), a TM1/TM5
Fig 2. Spontaneously assembled CXCR4 dimers. (a) Sampled CXCR4 dimer configurations in pure POPC bilayers after 3 μs (left), and in mixed POPC:
cholesterol bilayers after 6 μs simulation time at 10% (middle) and 30% cholesterol content (right). The β and χ angles are defined relative to the crystal
TM5,6/TM5,6 interface (central blue dots, see Methods Section for the exact definition of the angles β and χ). (b) Relative populations for the dimer
configurations defined in (a) and (c). (c) Representative dimer configurations corresponding to labeled maxima A to G in (a) are shown in cylindric
representation and colored equally as in Fig 1. Symmetric structures (C1 and C2 corresponding to TM1/TM5 and TM5/TM1, respectively) are distinguished
by indices 1 and 2. The reference structure for all dimer configurations is indicated by green and blue axes.
doi:10.1371/journal.pcbi.1005169.g002
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dimer (C, 24%), a loosely bound configuration via terminal TM5/TM5 contacts (A, 20%), and
a symmetric TM1/TM1 dimer (D, 13%). Interconversions between initially formed dimer
interfaces were hardly observedwith the exception of transitions between interfaces B and C
(compare S2 Table).
The most populated dimer configurationB (TM1/TM5-7) is in excellent agreement with
one of the available CXCR4 dimer crystal structures (marked as blue spots in Fig 2a, root mean
square deviation, RMSD, 3.9 Å, for a molecular view see Fig 3): The crystal structure (pdb
entry 3OE8 [17]) has a symmetric TM5,6/TM5,6 interface in a trimeric complex, but also con-
tains an interface formed by TM1 of one monomer and residues of TM5, TM6, and TM7 of the
second receptor (Figs 1b and 3a). Specifically, at the N-terminal side of the receptor, Lys38
(TM1) and the aromatic Phe276 form a π-H pair and Ile261 (TM6) interacts with the backbone
of Lys38. The central part of the interaction interface is built up by hydrophobic interactions
between leucines at positions 50 (TM1) and 253 (TM6). Contacts betweenVal54, Leu58, and
Val62 of TM1 and Leu216, Cys220, Ile223, and Ser224 of TM5 complete this dimeric CXCR4
interface at the C-terminal side.
The secondmost populated dimer configuration (C) contains an asymmetric TM1/TM5
interface. A similar interface was reported for the CCR5 chemokine receptor [25], although
there TM4 contributed as well to the interface. The symmetric TM1/TM1 interface (observed
for 13% of all spontaneously formed dimers in pure POPC,D) is also seen in the contact region
between two TM5,6/TM5,6 dimers in the crystal structure (compare Fig 1b, pdb entry 3OE9).
This dimer interface is mainly built by Thr43 and Ile47 of each receptor (RMSD between crys-
tal and simulated TM1/TM1 amounts to 4.1 Å, Fig 3b).
In contrast to the well reproduced TM1/TM5-7 and TM1/TM1 crystal dimers, the rather
compact TM5,6/TM5,6 crystal interface was not sampled in the simulations regardless of the
cholesterol concentration. The formation of this dimer interface was found to be hindered by sig-
nificant differences in the tilt of TM5 between the monomeric CXCR4 form (tilt of upper part of
TM5, Asp193-Met205, 28°; lower part of TM5, Val206-Ser227, 35°) and the TM5,6/TM5,6
Fig 3. TM1/TM5-7 and TM1/TM1 dimer interfaces and structure alignments. Structure alignments between spontaneously formed TM1/TM5-7
dimer (a) as well as TM1/TM1 dimer (b), obtained from a 3 μs simulation in pure POPC and backmapped to atomistic resolution (colored TM helices),
and the crystal structures of TM1/TM5-7 and TM1/TM1 found in PDB-entries 3OE8 and 3OE9, respectively (light grey). The interacting residues are
highlighted as sticks and labeled.
doi:10.1371/journal.pcbi.1005169.g003
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crystal dimer (tilts of 12° and 22°, respectively), a result that was obtained independent of the
membrane thickness (S2 Fig, S1 Table). I.e., under crystallization conditions the TM5 helix in the
symmetric TM5,6 dimer is orientedmore parallel to the (hypothetical)membrane normal as
compared to CXCR4 monomers in a phospholipid membrane. This finding suggests that the for-
mation of the crystal compact TM5,6/TM5,6 dimer in biologicalmembranes requires either
prior or induced receptor tilting upon dimerization or conformational receptor rearrangements
resulting in an altered TM5 tilt. Additionally, atomistic simulations of the crystal TM5,6/TM5,6
dimer showed an asymmetric orientation of the TM5 helix at the interface, suggesting a reduced
stability of the crystal TM5,6/TM5,6 CXCR4 dimer symmetry in a membrane environment
(S3 Fig).
A different picture emerges for the TM1/TM5-7 and TM1/TM1 dimer configurations.
Here, the TM5 helices of the simulated crystal dimers adopt similar orientations to those
observed in CXCR4 monomer simulations.
Cholesterol-conditioned changes of the CXCR4 dimerization interface
The presence of cholesterol in the lipid bilayer significantly affected the preference for the for-
mation of different dimers.While the population of dimerA (loose TM5/TM5 dimer) was only
slightly affected, the population of dimers including helices TM1 and TM5-7 (dimers B, C, and
D) decreased significantly with increasing cholesterol concentration. At high cholesterol con-
centration, the formation of dimers B and D (found in crystal structures) is impeded resulting
in relative populations of only 5%. On the other hand, in the presence of cholesterol dimers
interacting via the TM3,4 interface (dimers F,G) are substantially enhanced. The abundance of
the asymmetric dimerG (TM1,7/TM3-5 interface) was already enhanced at 10% cholesterol
content while the occupancy of the symmetric dimer F (TM3,4/TM3,4), hardly sampled in a
pure POPCmembrane ( 1%), increased to 20% at high cholesterol concentration. These
changes in the dimerization profile were largely induced by specific cholesterol-receptor inter-
actions (see below).
Cholesterol binding sites on CXCR4. As shown in Fig 4 and in S4 Fig, cholesterol binds
to distinct areas on the CXCR4 monomer. The highest cholesterol occupancy, with cholesterol
bound for 65% of the simulation time, was observed for a binding spot between helices TM1
and TM7 (shown in detail in the insert of Fig 4 and named lower TM1,7). This binding spot
involves residues Ile47, Leu50, Thr51, Val54, Leu58 on TM1, as well as Cys296 and Ile300 on
TM7. The average contact time of a bound cholesterol molecule at the TM1,7 binding spot was
6 ns. On the upper part of the TM1 helix another cholesterol binding spot (upper TM1) is
located. This spot involves residues Ile39, Pro42, Thr43, Ser46, and Ile47 and the average con-
tact time of bound cholesterol was 5.8 ns. Also the TM5 helix shows strong cholesterol binding
as in total three cholesterol binding spots could be identified: The first, upper TM5, consists of
Leu194, Val198, Phe201, and Gln202 and cholesterol was on average for 5.1 ns in contact with
these residues. The second cholesterol binding spot, termed central TM4,5, is formed by resi-
dues Met205, Val206, Ile209, and Leu210 on TM5 as well as by Pro163 and Leu167 on TM4.
The average cholesterol contact time for this spot was 2.7 ns, as compared to 4.5 ns for the
third binding spot termed lower TM5. The latter cholesterol binding region is formed by
Leu216, Ser217, Cys220, Ile221, Ile223, Ser224, and Lys225. Cholesterol binding becamemore
pronounced and less specific for higher cholesterol concentrations (S5 Fig).
Overall, cholesterol binds to the protein mainly via hydrophobic interactions, i.e. hydropho-
bic residues showed the highest cholesterol occupancies. The spatial distribution functions of
cholesterol and its polar headgroup around the receptor revealed that the orientation of bound
cholesterol molecules is quite restricted for each binding hot spot (see S4 Fig). Consequently,
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cholesterol appears to associate with the receptor due to shape-driven interactions allowing the
molecules to cover certain parts of the rugged surface of CXCR4.
The specific cholesterol binding spot on TM1,7 is responsible for the reduction of CXCR4
dimerization discussed above via TM1 and TM7 by partial steric blocking of these interaction
surfaces.
The reported conserved cholesterol consensus motif (CCM, primarily located on TM4),
that was found for the β2 adrenergic receptor [43], could not be identified. In addition,
enhanced binding to possible cholesterol recognition amino acid consensus (CRAC) motifs, as
suggested for the serotonin 5-hydroxytryptamine(1A) receptor [44], did not appear in the sim-
ulations, eventhough three CRAC motifs could be identified in the sequence of CXCR4. These
observations are in agreement with a cholesterol docking study on CXCR4 [45].
Cholesterol intercalation stabilizes a symmetricTM3,4/TM3,4 dimer interface of
CXCR4. Cholesterol additionally temporarily occupied the TM3,4 interface. However, the
steroid does not specifically bind at the dimerization interface but rather fills up free volume at
Fig 4. Cholesterol occupation hotspots on CXCR4. Cholesterol binding occupancy in simulations of CXCR4 dimerization at 10% cholesterol
concentration. The color and thickness coded residue-resolved occupancy scale ranges from 0 to 65% time occupancy (red, thick). The inset
shows a detailed view on the main cholesterol binding site at the TM1,7 interface with the main involved residues in stick representation.
Additionally, a bound cholesterol molecule is depicted (gray).
doi:10.1371/journal.pcbi.1005169.g004
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this interface. As shown in Fig 5, two symmetrically bound cholesterol molecules intercalate,
together with a few water molecules, into the TM3,4 interface (compare also S6 Fig). Phospho-
choline lipids can neither fill this space from the top nor from the bottom layer because the cav-
ity is isolated within the bilayer hydrophobic core.
The presence of cholesterol molecules at TM3,4 is responsible for the cholesterol-induced
increase of the populations of dimersG and F. For the former, asymmetric one, only one inter-
action interface is formed by helices TM3,4. As only one cholesterol molecule is required for
this dimer to be formed, even low cholesterol concentrations are sufficient to enhance the for-
mation of dimerG. In case of the symmetric dimer F (two TM3,4 interfaces) two cholesterol
molecules have to be bound simultaneously to smoothen the interaction surface (S2 Video).
Therefore, the probability of this compact dimer increases with increasing cholesterol
concentration.
Discussion
The function of several G protein coupled receptors was shown before to be coupled to dimer-
ization. Recent pieces of evidence further prompted to the existence of multiple dimer inter-
faces, and the selective importance of individual interfaces for signaling. In addition,
crystallographic studies suggest that GPCRs may adopt type-specificdimer configurations,
despite their structural similarity.
Here, based on ensembles of dimerization simulations, a high plasticity of the dimer inter-
face of the chemokine receptor CXCR4 is reported. Three compact dimer structures emerged
as main configurations in a cholesterol-freemembrane, involving a TM1/TM5-7 interface, a
TM1/TM5 interface, as well as a symmetric TM1/TM1 configuration. Interestingly, the sym-
metric and compact dimer including helices TM5 and partially TM6, predominant in crystals
of the receptor, could not be reproduced in the membrane environment. The reason for this
difference could be ascribed to the different orientations of the TM5 helix in the membrane-
embeddedCXCR4 monomer and the crystal TM5,6/TM5,6 dimer.
In cholesterol-depletedmembranes CXCR4 is known to be inactive [15]. GPCR activation
and desensitization are connectedwith movements of TM6 and TM7, respectively [41]. There-
fore, in the absence of cholesterol, the involvement of these helices in the dimerization inter-
face, as reported here, is likely to hinder their activation-related movements resulting in
chemotaxis-inactive dimers. This interpretation is further supported by a FRET study [15] that
reported only a small reduction of FRET signals (15–20%) betweenCXCR4 proteins upon
depletion of cholesterol, while the CXCR4 chemotaxis response to CXCL12 was completely
abolished. Either the binding of the CXCL12 ligand (or its dimer) is disabled or the G protein
signaling is disrupted.
Addition of cholesterol drastically affected the dimerization pattern: The cholesterol binding
betweenTM1 and TM7 mostly disabled the formation of the TM1/TM5-7 dimer. In turn, a
new cholesterol-induced symmetric TM3,4 dimer was enabled. This novel TM3,4 CXCR4
binding mode in cholesterol-rich membranes is corroborated by the experimental finding that
addition of TM4 peptides weakened CXCR4 interactions and signaling in malignant cells [15];
the binding of TM4 peptides to CXCR4 likely competes with dimerization at this interface.
Additional experimental support for the functional role of dimerization for signaling is pro-
vided by earlier work of Percheranicer et al. on HEK cells: Using BRET the authors demon-
strated a CXCL12-induced rearrangement of CXCR4 homodimers coupled to the activation of
the receptor [16]. TM6 and TM7 peptides did not affect these CXCL12-induced configu-
rational changes, however, addition of these transmembrane peptides significantly lowered the
receptor signaling.
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Fig 5. Cholesterol intercalation at the cholesterol-induced dimeric interface. TM3,4/TM3,4 dimer F
with two symmetrically intercalated cholesterols (shown as hotpink sticks) (structure after 100 ns atomistic
MD simulation). The surrounding membrane is shown in light orange (POPC) and teal (cholesterol) sticks. In
the insert, the two intercalating cholesterol molecules are highlighted together with their surroundings and
water molecules (shown as spheres) forming bridges between the cholesterols and between Thr168 and
cholesterol.
doi:10.1371/journal.pcbi.1005169.g005
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Together with our results, this experimentmay be interpreted as follows: We assume a pool
of different dimers, both active or activatable and inactive, formed by CXCR4 in cholesterol
containing cells. Upon addition of CXCL12 the preformed TM3,4 homodimers are stabilized
by the interaction with the ligand, shifting the pool towards this dimer configuration and
resulting in the observed increased BRET intensity and receptor signaling. Addition of TM4
peptides impedes the formation of this complex resulting in drastically decreased BRET inten-
sity and receptor signaling [15, 16]. In turn, addition of TM6 and TM7 peptides hardly affect
the formation of the activation-competent TM3,4 dimer but probably blocked receptor activa-
tion by binding to the activation site. Therefore, not the BRET intensity but the activity is influ-
enced by the presence of TM6 or TM7 peptides in the experiment [16]. This in turn supports
the conclusion derived above, that dimers including TM6 at the interaction interface likely rep-
resent inactive dimers.
Activation-competent CXCR4 dimers are therefore suggested to necessitate binding via the
TM3,4 interface which can only be achieved by cholesterol intercalation as shown here.
To further validate these findings, a number of experiments could be performed to analyse
different aspects of the discussed results. E.g., cross-linking experiments are highly effective in
identifying TM helices that contribute to dimeric interfaces and further to test dimer function.
In a similar way as performed by Guo et al. [34], cross-linking different sets of substituted cys-
teines on distinct TM helices will provide experimental insight in how different dimer inter-
faces can affect agonist-induced activation. Adding agonists to cross-linked TM1/TM5-7
dimers, should result in reduced CXCR4 signaling as compared to adding agonists to cross-
linked TM3,4/TM3,4 dimers. In order to address the functionality of cholesterol-induced
TM3,4/TM3,4 dimers, mutations of residues on TM3 and TM4 can be introduced that stabilize
this interface in the absence of cholesterol, e.g. mutations that insert bulky and hydrophobic
residues in order to pad the otherwise cholesterol-filled volume at the interface (e.g.
Leu166Phe, Thr168Trp or Ile169Phe). According to our observations, CXCR4 signaling is sug-
gested to be less cholesterol-dependent for these mutants.
In summary, our results suggest a highly dynamic dimerization pattern for the chemokine
receptor CXCR4, and provide evidence for a modulation of the dimerization pattern by the
membrane composition. In agreement with experiments, the total dimerization is only slightly
affected by cholesterol while the specificity of the interaction interface and thus probably the
signaling capability are drastically altered.
Materials and Methods
All dimerizationmolecular dynamics simulations were prepared using DAFT [30] and per-
formed with GROMACS 4.6.x [46] using the coarse-grainedMartini force field [47]. In total,
three CXCR4 (Fig 1a) dimerization assays with 0%, 10%, and 30% cholesterol content in a
POPC lipid bilayer were studied, comprising 500 independent simulations each. The simula-
tion lengths were 3 μs each for the pure POPC bilayer systems and 6 μs for the mixed POPC:
cholesterol membranes (consisting of POPC:cholesterol in 9:1 ratio and in 7:3 ratio) in order to
account for the reduced diffusion and dimerization kinetics of the receptors.
The orientation of CXCR4 monomers in membranes of varying thickness as well as the
preferential cholesterol binding sites were addressed in additional simulations at both CG and
atomistic resolution. Moreover, for analysis of the dimer interfaces and lipid-protein interac-
tions selectedCG structures were converted back to atomistic resolution [48] and relaxed
atomistically.
For an overviewover all performedCG and atomisitic simulations see Tables 1 and 2,
respectively.
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Table 1. Overview over all performed coarse-grained simulations.
Coarse-grained systems Number of simulations Simulation length
Dimerization set-ups
POPC 501 3 μs
POPC/10%Cholesterol 501 6 μs
POPC/30%Cholesterol 499 6 μs
Monomers
POPC 10 200 ns
POPC/10%Cholesterol 10 1 μs
POPC/30%Cholesterol 10 200 ns
DEPC 10 200 ns
GMO/6%Cholesterol 10 200 ns
Membranes
POPC 1 200 ns
POPC/10%Cholesterol 1 200 ns
POPC/30%Cholesterol 1 200 ns
DEPC 1 200 ns
GMO/6%Cholesterol 1 200 ns
TM5,6/TM5,6 crystal dimer
POPC 1 3 μs
POPC/10%Cholesterol 1 3 μs
POPC/30%Cholesterol 1 3 μs
TM1/TM5-7 crystal dimer
POPC 1 3 μs
POPC/10%Cholesterol 1 3 μs
POPC/30%Cholesterol 1 3 μs
TM1/TM1 crystal dimer
POPC 1 3 μs
POPC/10%Cholesterol 1 3 μs
POPC/30%Cholesterol 1 3 μs
doi:10.1371/journal.pcbi.1005169.t001
Table 2. Overview over all performed atomistic simulations.
Atomistic systems Number of simulations Simulation length
Monomers in POPC
CHARMM36 1 500 ns
Amber14/Lipid14 1 200 ns
pure POPC membranes
CHARMM36 1 500 ns
Amber14/Lipid14 1 510 ns
TM5,6/TM5,6 crystal dimer in pure POPC
CHARMM36 1 200 ns
Amber14/Lipid14 1 200 ns
TM3,4/TM3,4 dimer in POPC/30%Cholesterol
GROMOS54a7 1 100 ns
doi:10.1371/journal.pcbi.1005169.t002
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System preparation
The dimer crystal structure 3OE0 [17] was obtained from the Protein Data Bank and adjusted
in the following way: First, all non-protein atoms, one monomer, and lysozyme (cocrystallizing
agent) were removed. Then, the mutations of residues L125W and T240P, required for crystal-
lization, were mutated back to represent the wild type protein. In the end, two missing intracel-
lular loops were modelled by MODELLER [49] (The loop comprising K67, K68, L69, and R70
was not resolved in the crystal structure and in place of residues S229 and K230 lysozyme was
present in the crystal structure.). The MODELLER output structure was energy-minimized
using the GROMOS54a7 force field [50]. Because the termini were not resolved in the crystal
structure, the final model contained 279 (25–303) of the 352 residues of the CXCR4 protein.
Coarse-grained simulations
The DAFT procedure involved the following steps: First, atomistic structures of CXCR4 were
converted to the Martini2.2 CG force field [47] usingmartinize [47]. The secondary and ter-
tiary structure of the protein was assured to be stable by applying a RubberBand network for all
backbone bead pairs within the distance of 0.9 nm and excluding the i − i + 1 and i − i + 2 pairs
(which are connected by bonds and angles within the Martini force field). The RMSD of the
TM helices of CXCR4 was as low as 1.5 Å (500 ns, CHARMM36 force field) or even 1.0 Å
(Amber14sb/Lipid14) in atomistic simulations of CXCR4 (see below). Therefore, the applica-
tion of structural restraints in the coarse-grainedmodel is not expected to influence the results
on receptor dimerization.
CG proteins were randomly rotated around the z-axis and placed in pairs with the mini-
mum distance of circumscribed spheres of 3.5 nm into a rhombic box. In the next step a CG
lipid bilayer [51], either pure POPC or mixed POPC/cholesterol with 9:1 or 7:3 ratio, and CG
water [52] were added by insane [53, 54]. Those systems were then passed tomartinate [55]
where they underwent 500 steps of steepest-descent energyminimization and 10 ps of position
restrained NVT simulation with a 2 fs time step. Furthermore, 100 ps of MD simulation in an
NpT ensemble with a 20 fs time step were performed to heat the system to 310 K and adjust
the pressure to 1 bar. Production runs succeeded in an NpT ensemble, where the temperature
was kept at 310 K by applying the Berendsen thermostat [56] with a 1 ps time constant. The
pressure was controlled in a semi-isotropicalmanner (xy and z were independent) to 1 bar
using the Berendsen barostat [56] with a 3 ps time constant. The relative permittivity was set to
be 15 and the electrostatic interactions were shifted to 0 between 0 and 1.2 nm. The van der
Waals forces were describedby the 12-6 Lennard-Jones potential that was shifted to zero
between 0.9 and 1.2 nm. The integration time step was 20 fs and the movement of the center of
mass of the system was removed linearly every 10 steps.
CG dimerization simulations. A typical dimerization setup contained two copies of
CXCR4, a lipid membrane made either out of approx. 320 POPC, 375 POPC/40 cholesterols
(POPC/10% cholesterol) or out of 255 POPC/110 cholesterols (POPC/30% cholesterol) sur-
rounded by about 7,000 CG water molecules, corresponding to a ratio of about 1:20 lipid:CG
water.
CG crystal dimer simulations. The three different crystal dimers were extracted from the
crystal structures 3OE9 (TM5,6/TM5,6 and TM1/TM1 dimers) and 3OE8 (TM1/TM5-7
dimer) and the sequence (both length and mutations required for crystallization)was adjusted
to equal the sequence used for the DAFT setup described above. The crystal dimer simulations
were performed in all three membrane compositions of interest (build by insane [53, 54]) and
the protein:lipid:water ratios as well as the simulation procedure were chosen similar to the
DAFT dimerization simulations.
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CGmonomer simulations. The positioning and dynamics of single CXCR4 molecules in
membranes of different thickness and composition, was addressed in assays of 10 simulations
each of 200 ns length. Cholesterol binding hotspots on CXCR4 in a membrane were studied at
a reduced cholesterol content (POPC/10% cholesterol) for 1 μs. All single protein simulations
included one CXCR4 receptor, about 250 lipids, and were solvated by approx. 4,300 CG water
molecules.
CG pure bilayers. Similarly, for comparison of lipid diffusion and the bilayer thickness in
an unperturbedmembrane, pure membrane systems (260 POPC, 304 POPC/32 cholesterols
(POPC/10% cholesterol), 214 POPC/92 cholesterols (POPC/30% cholesterol), 246 DEPC, and
365 GMO/22 cholesterols (GMO/6% cholesterol) each solvated by about 4,300 CGwater mole-
cules) were simulated for 200 ns each.
A summary of all coarse-grained simulations is given in Table 1.
Atomistic simulations
Atomistic simulation systems were set up in Gromacs 5.0.4 [57] by backmapping relaxed
coarse-grained systems to an atomistic resolution (either CHARMM36 [58, 59] or Amber14sb/
Lipid14 [60–62] force fields) using backward [48]. In case of crystal structure simulations the
correspondingmonomer or dimer crystal structures were fitted on the backmapped structures
and energyminimized. Before production run simulations, 2 ns simulations were performed
with position restraints applied on the protein. The final simulation runs were performed in
the NpT ensemble, where the temperature was kept constant at 310 K using the v-rescale ther-
mostate [63] with a coupling time constant of 0.5 ps. The pressure was controlled semiisotropi-
cally to stay at 1 bar. The center of mass motion was removed for the whole simulation system.
The simulation of the TM3,4/TM3,4 dimer in POPC with 30% cholesterol content was pre-
pared in GROMACS 4.6.5 using the GROMOS54a7 [50] force field. The particle mesh Ewald
summation [64] was applied to compute the long-range electrostatics. For further simulation
details see Pluhackova et al [65]. A summary of all atomistic simulations is given in Table 2.
Analysis
Dimerization criterium. Two proteins were considered to be a dimer, if the interaction
energy (sum of Lennard-Jones and Coulomb interaction energy) between their TM helices
(defined in Fig 1) was below -50 kJ/mol.
Dimer binding free energy. Based on the time evolution of the number of dimerized sim-
ulations, the reaction rate constant k and the dissociation constant KD were estimated as fol-
lows: The dimerization reaction rate constant k was directly derived from the concentration of
monomers in all simulations as a function of simulation time (Fig 6) assuming a first-order
reaction. The rate constants decrease with the increased amount of cholesterol in the mem-
brane (Table 3).
The dissociation constants KD and the corresponding binding free energiesΔG were





c⊘ is the standard concentration of 1 mol/l,NAv the Avogadro constant, and V the volume of
the lipid-protein double layer. P0,1 are the fractions of simulation time in monomeric and
dimeric states, respectively. The above equation is valid in thermodynamic equilibrium; there-
fore, only those monomer states were counted that arose from dissociation of receptor dimers.
Dissociation events were defined as a change of the protein-protein interaction energy from
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Fig 6. Concentration of receptor monomers as a function of simulation time. The first 500 ns were discarded for equilibration purposes.
doi:10.1371/journal.pcbi.1005169.g006
Table 3. Reaction rate constants, dissocation constants as well as binding free energies.
Setup k in 106 s−1 a P0/P1 b V in nm3 c KD d ΔG in kJ/mol e
POPC 0.274 0.0309 566.4 9.06  10−5 -23.98
POPC/10%Cholesterol 0.156 0.0858 610.2 2.34  10−4 -21.54
POPC/30%Cholesterol 0.057 0.1733 605.6 4.75  10−4 -19.71
a Dimerization reaction rate constants k derived from Fig 6.
b P0/P1 denotes the ratio between times spent in monomeric states (after dissociation) and dimeric states in the simulation setups.
c V is the total volume of the protein-lipid bilayer.
d Estimated dissociation constants KD.
e The binding free energies ΔG should be considered as lower bounds for the true binding free energies as the number of dissociation events decreases
with increased simulation times.
doi:10.1371/journal.pcbi.1005169.t003
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values below -50 kJ/mol to more than -1 kJ/mol. Histograms of these monomer lifetimes are
shown in Fig 7 and the results for KD and ΔG = RTlnKD are summarized in Table 3.
Orientation analysis. Ensembles of simulations were analyzed to characterize the relative
binding of the receptors. To that end, the configurations of the receptors were assigned a center
of mass and principal components defining an internal coordinate frame (described in detail in
[30]). From the superimposition of the coordinate frames, the COM distance and five angles
were computed that describe the relative orientation of the proteins. The angles used in this
work are graphically illustrated in Fig 8.
The position, angle β, defines the binding position of the partner to the reference protein.
The rotation of the partner around its own z-axis is called phase and denoted as φ. The angle χ,
Fig 7. Histograms of monomer lifetimes after dissociation of dimers.
doi:10.1371/journal.pcbi.1005169.g007
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calculated as χ = (180° + β − φ)mod360, describes under which angle the reference protein
binds on the partner protein. Examples of two binding modes are shown in Fig 9. Panel a
shows the so called back-to-face or also face-to-back binding mode corresponding to binding
of helices TM5/TM1 or TM1/TM5 and angles β = 0°, χ = 180° or β = 180°, χ = 0°, respectively.
In panel b the face-to-face binding of TM5,6/TM5,6 corresponding t o β = 0° and χ = 0° is
shown. The β and χ angles were calculated for all spontaneously formed dimers for the last 50
ns of the simulation time. Subsequently, the kernel densities of all points in the β/χ-space were
computed, which resulted in the density height-fields shown in Fig 2. Here the angles β and χ
Fig 8. Relative orientation angles used to describe the orientation of the monomers in the receptor dimer. β describes the position of monomer B
with respect to monomer A, φ is the rotation of monomer B around its z-axis, χ the angle under which monomer B “sees” monomer A. The axes x and y
were placed into the monomer in a way that the symmetric TM5,6/TM5,6 dimer results in β = 0 and χ = 0.
doi:10.1371/journal.pcbi.1005169.g008
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were sampled on the x and y axis, respectively. The probability of occurrences is the height
encoded by color (white—red—yellow).
Finding label boundaries. The height-field resulting from the orientation angle analysis
was examinedmore closely using methods from image processing.
First, the most frequent binding modes were found by computing the local maxima of the
height-field. To examine the spreading of these maxima the watershed transform [67], a
method originally used in image segmentation, of the height-field was computed. The basic
idea is to consider the negative height-field as a topographic surface which is gradually filled
with water and use the arising watersheds, where the water flows from one basin to another, as
borders of the area of influence for the maximum assigned to each basin.
Simulated immersion [67] was adapted here to compute the watershed transform. There-
fore, the pixels are sorted descending by height and a label image is initializedwith distinct
label values for each maximum. Subsequently, the 4-neighborhoodof the sorted pixels was
examined iteratively and the pixels were assigned to either one of the labels, if this label was
unique in its neighborhood, or watershed, if two or more different labels were present. Pixels
that could not be assigned in the first step, were processed in a second iteration where the
neighborhood size was increased in case of slow convergence.
As angles are circular data, the infinite repetition of the height-field in x and y direction had
to be taken into account. By adding up the probabilities for all angle combinations falling into
one area, the spreading of its maximumwas computed. Results thereof are shown in Fig 10. In
a next step, all simulation-frames were assigned to the different labels allowing for further dif-
ferentiated analyses of dimer characteristics like the number of intercalating cholesterol
molecules.
Lipid and protein lateral diffusion. Lateral self-diffusion coefficients of both lipids and
proteins were calculated from the slope of the mean square displacement (MSD) of the beads
Fig 9. Relative orientation angles for TM5/TM1 or TM1/TM5 dimers a, corresponding to β = 0˚, χ = 180˚ or β = 180˚, χ = 0˚, respectively. The
symmetric TM5,6/TM5,6 dimer b binds with β = 0˚ and χ = 0˚.
doi:10.1371/journal.pcbi.1005169.g009
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where Δr(t) is the distance that the bead travelled in time t. The slope of the MSD was fitted on
the time window between 5–20 ns. The MSD was calculated on the initial 200 ns for those sim-
ulations that were not dimerized after 250 ns. The center of mass motion of the membrane-
protein system was substracted prior to the MSD calculation.
Cholesterol binding sites. A cholesterol molecule was considered as bound, if one of the 8
cholesterol beads was located within 0.62 nm of the protein. This distance corresponds to the
size of the first solvation shell of cholesterol beads around the protein as obtained by the radial
distribution function (RDF) calculation. The calculation was performed in an interval from
200 to 1000 ns for both cholesterol concentrations. The first 200 ns were discarded in order to
exclude random protein-cholesterol contacts due to membrane construction around the pro-
teins. In order to detect cholesterol binding residues, the average time for which any cholesterol
Fig 10. Spreading of each maximum in different dimerization set-ups.
doi:10.1371/journal.pcbi.1005169.g010
Table 4. Diffusion constants.
Membrane Molecule 0a 1b 2c
POPC protein 0.44 ± 0.14 0.51 ± 0.13
POPC 5.53 3.94 ± 0.21 3.67 ± 0.15
POPC/10% cholesterol protein 0.33 ± 0.03 0.47 ± 0.12
POPC 4.75 3.31 ± 0.06 3.26 ± 0.13
Chol 6.23 4.15 ± 0.21 4.14 ± 0.31
POPC/30% cholesterol protein 0.22 ± 0.07 0.26 ± 0.06
POPC 2.78 2.12 ± 0.13 1.93 ± 0.08
Chol 3.39 2.56 ± 0.10 2.26 ± 0.12
Protein and lipid diffusion coefficients in 10−7cm2/s (average and standard deviation).
a Pure bilayer simulations.
b Simulations including one copy of CXCR4 in the membrane.
c Simulations including two copies of CXCR4 in the membrane.
doi:10.1371/journal.pcbi.1005169.t004
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was in contact with this residue was calculated. A similiar approach was used in [44]. Addition-
ally, the number of cholesterol molecules located at the dimer interface in simulations with
10% and 30% cholesterol content was determined by analysis of cholesterol molecules bound
to both monomers at the same time.
Bilayer thickness. The thickness (S1 Table) of phospholipid membranes was calculated as
the difference of the maxima of the PO4 bead (or P atom in atomistic simulations) density pro-
file along the membrane normal. In case of GMO, the density of its first bead (GL1) was
utilized.
The bilayer thickness in the vicinity of the protein was calculated for lipids within 1 nm dis-
tance to the protein in each trajectory frame by substracting the z position of the PO4 bead (or
GL1 bead for GMO or P atom in atomistic simulations) in the upper and lower leaflet by a
home written script.
Supporting Information
S1 Video. Video of an example dimerization of CXCR4 in a pure POPCmembrane.After
approximately 1 μs a stable dimer had assembled. The dimeric TM1/TM5-7 interface is shown
in a coarse-grained representation first and later at atomistic resolution.
(MOV)
S2 Video. Video of an example dimerization of CXCR4 in a POPCmembrane with 30%
cholesterol content. The dimer was formed after approximately 5 μs. The symmetric TM3,4/
TM3,4 dimer interface with intercalating cholesterol molecules is shown in a coarse-grained
representation and is then backmapped into an atomistic model.
(MOV)
S1 Fig. Evolution of number of dimers in time.Number of CXCR4 dimers formed in 500
simulations of two monomers each in phospholipid bilayers (POPC) at 0%, 10%, and at 30%
cholesterol content as a function of simulation time. The receptors were defined to have formed
a dimer if the intermolecular interaction energy between the two transmembrane domains
decreased below a threshold of -50 kJ/mol.
(TIF)
S2 Fig. TM5 tilt angles in coarse-grainedsimulations.Tilt angles between the first principal
axis of the upper part (Asp192-Met205) or the lower part of TM5 (Val206-Ser277) and the
membrane normal. For every environment (POPC, POPC/10% cholesterol, and POPC/30%
cholesterol), the tilt angles of both monomers, shown for label A (TM5/TM5), B (TM1/TM5-
7), and D (TM1/TM1), were calculated for the last 50 ns of the simulation and are shown in
red. Angles of the best corresponding crystal dimer structures, calculated over the first 500 ns
of CG simulations, are shown in blue (monomer A) and green (monomer B). In the inset, the
tilt angles of receptors in monomer configuration are compared for different lipid environ-
ments of the receptor. The vertical lines denote the mean tilt angles as determined from the ini-
tial 500 ns of CG simulation of the given crystal CXCR4 dimers in pure POPC. Overall, the
TM5 tilts are similar betweenmonomer and the different spontaneously assembled dimers.
These angles differ significantly from those for the TM5 orientation of simulations of the crys-
tal symmetric TM5,6/TM5,6 dimer for all studied lipid compositions.
(TIF)
S3 Fig. TM5 tilt angles in atomistic simulations.Comparison of tilt angles of upper (top) and
lower (bottom) TM5 subhelices relative to the membrane normal in monomers and the
TM5,6/TM5,6 dimer between coarse-grained and atomistic simulation. Overall, the TM5 tilt
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angles of the monomeric CXCR4 agree well betweenCG and atomistic simulations using the
Amber14/Lipid14 force field combination. Atomistic simulations of the symmetric crystal
dimer configuration exhibit asymmetric distributions for the tilt of the upper part of TM5, sug-
gesting instability of this symmetry. The tilt angles of the lower part of TM5 show a very good
agreement betweenCG and atomistic resolution using the Amber14/Lipid14 combination.
(TIF)
S4 Fig. Spatial distribution function of cholesterol around CXCR4. The spatial distribution
functions of the five nearest cholesterol molecules around CXCR4 are shown in light orange,
distribution functions of the polar headgroup of cholesterol (ROH beads) are colored dark red.
CXCR4 is colored according to the scheme established in Fig 1. The increasing cartoon thick-
ness codes the residue-resolved cholesterol occupancy (compare Fig 4).
(TIF)
S5 Fig. Cholesterol occupancy in POPC with 30% of cholesterol.Cholesterol binding occu-
pancy in simulations of CXCR4 dimerization at 30% cholesterol concentration. The increasing
cartoon thickness and coloring scheme code the relative cholesterol occupancies, from 0%
(thin, blue) to 100% (thick, red).
(TIF)
S6 Fig. Intercalation of cholesterol at dimer interfaces.Probability of finding at least one
cholesterol molecule at different dimer interfaces for both mixed bilayers (top panel) and the
number of intercalating cholesterol molecules (bottom panel). The analysis was performed
over the final 50 ns of all simulations.
(TIF)
S1 Table. Monomer tilt angles andmembrane thickness.Tilt angles between the main princi-
ple axis of the protein’s transmembrane domain and the membrane normal, as well as mem-
brane thicknesses.
a Total number of simulations in the respective set-up used for the analysis.
b Tilt angle of the principle axis of a CXCR4 monomer relative to the membrane normal (aver-
age and standard deviation).
c The thickness of the lipid bilayer in a 1 nm surrounding of the receptor.
d The thickness of the bilayer in protein-free simulations (one simulation per bilayer type and
representation was performed). The CGmembranes were simulated for 200 ns and the thick-
ness was calculated over the last 100 ns.
e The simulation of a pure POPC bilayer using the (atomistic) CHARMM36 force field was car-
ried out for 110 ns.
The preferred bilayer thickness around CXCR4 monomers in CG simulations was determined
to 4.25 nm. Accordingly, CXCR4 locally thins membranes displaying a larger thickness in
the simulations (POPC/30% cholesterol and 1,2-Dierucoyl-sn-glycerol-3-phosphocholine
(DEPC) membrane), and increases the thickness of thin membranes (POPC). Interestingly, the
thickness of a glycerol monoleate (GMO) environment for CXCR4 monomers is not signifi-
cantly influenced by the presence of the receptor. The probable reason for this behavior is the
missing charged phosphocholine headgroup of GMO. It is interesting to note, that CXCR4 was
crystallized in a GMO/10% cholesterol PEG stabilizedmatrix. POPCmembranes in atomistic
simulations were found to be 2–3 Å thinner as compared to their CG counterparts. Accord-
ingly, the thickness of atomistic POPCmembranes was as well enlarged in the vicinity of the
protein (at most for the Lipid14 parameters by 3 Å). The TM5,6/TM5,6 crystal dimer was
observed to significantly thin both POPC and POPC/10% cholesterol membranes.
(PDF)
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S2 Table. Interconversions between different dimer interfaces.Comparison of the number
of initially formed and final CXCR4 dimer configurations in pure POPC, POPC at 10% choles-
terol, and POPC at 30% cholesterol content. Configurationsmarked by ‘n’ did not belong to
any of the seven defined dimer configurations (labelsA throughG). Additionally, the total
number of respective dimer configurations at the end of the microsecond association simula-
tions is provided. In most of the simulations, the initially formed dimer configurations were
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